Martha Nason

19.7k total citations · 2 hit papers
85 papers, 5.1k citations indexed

About

Martha Nason is a scholar working on Virology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Martha Nason has authored 85 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Virology, 35 papers in Epidemiology and 33 papers in Infectious Diseases. Recurrent topics in Martha Nason's work include HIV Research and Treatment (37 papers), Immune Cell Function and Interaction (14 papers) and HIV/AIDS Research and Interventions (12 papers). Martha Nason is often cited by papers focused on HIV Research and Treatment (37 papers), Immune Cell Function and Interaction (14 papers) and HIV/AIDS Research and Interventions (12 papers). Martha Nason collaborates with scholars based in United States, United Kingdom and Switzerland. Martha Nason's co-authors include Mario Roederer, John R. Mascola, Barney S. Graham, Richard A. Koup, Daniel C. Douek, Gary J. Nabel, Jason M. Brenchley, Irini Sereti, James D. Neaton and Robert T. Bailer and has published in prestigious journals such as Nature, New England Journal of Medicine and Nature Communications.

In The Last Decade

Martha Nason

83 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection

2011 856 citations Netanya G. Sandler, Handan Wand et al. The Journal of Infectious Diseases profile →
SPICE: Exploration and analysis of post‐cytometric complex multivariate datasets

2011 614 citations Mario Roederer, Martha Nason et al. Cytometry Part A profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martha Nason United States	34	2.4k	2.3k	1.9k	1.4k	823	85	5.1k
Hendrik Streeck United States	42	3.4k 1.4×	4.3k 1.9×	1.9k 1.0×	1.2k 0.9×	1.1k 1.3×	116	6.8k
Ruth I. Connor United States	34	4.0k 1.7×	2.4k 1.0×	2.7k 1.4×	1.1k 0.8×	1.0k 1.3×	63	5.5k
Zabrina L. Brumme Canada	37	3.9k 1.6×	1.8k 0.8×	2.9k 1.5×	880 0.6×	884 1.1×	176	5.3k
Yvonne J. Bryson United States	41	2.7k 1.1×	1.5k 0.7×	2.8k 1.4×	2.8k 2.0×	514 0.6×	143	6.3k
Phalguni Gupta United States	38	3.0k 1.2×	1.6k 0.7×	2.5k 1.3×	1.1k 0.8×	903 1.1×	165	5.5k
Merlin L. Robb United States	45	4.8k 2.0×	2.4k 1.1×	4.0k 2.1×	1.8k 1.3×	1.1k 1.4×	249	7.8k
Shyam Kottilil United States	41	1.8k 0.7×	2.6k 1.2×	1.9k 1.0×	3.8k 2.8×	680 0.8×	209	7.6k
Michael A. Polis United States	43	4.3k 1.8×	2.8k 1.2×	3.5k 1.8×	2.9k 2.1×	656 0.8×	143	8.6k
William Borkowsky United States	39	3.8k 1.6×	2.6k 1.1×	2.8k 1.4×	2.3k 1.7×	621 0.8×	155	6.7k
Javier Martínez‐Picado Spain	46	5.6k 2.3×	2.2k 1.0×	4.3k 2.2×	1.0k 0.7×	1.6k 2.0×	221	7.7k

Countries citing papers authored by Martha Nason

Since Specialization

Citations

This map shows the geographic impact of Martha Nason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha Nason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha Nason more than expected).

Fields of papers citing papers by Martha Nason

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martha Nason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha Nason. The network helps show where Martha Nason may publish in the future.

Co-authorship network of co-authors of Martha Nason

This figure shows the co-authorship network connecting the top 25 collaborators of Martha Nason. A scholar is included among the top collaborators of Martha Nason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martha Nason. Martha Nason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nason, Martha, Jimmy D. Dikeakos, Sarah Joseph, et al.. (2025). The role of Nef in the long-term persistence of the replication-competent HIV reservoir in South African women. Journal of Virology. 99(7). e0021725–e0021725. 1 indexed citations

Proschan, Michael A., Martha Nason, Ana M. Ortega‐Villa, & Jing Wang. (2024). Changing interim monitoring in response to internal clinical trial data. Biometrics. 80(1).

Ortega‐Villa, Ana M., Martha Nason, & Dean Follmann. (2021). The mechanistic analysis of founder virus data in challenge models. Statistics in Medicine. 40(20). 4492–4504.

Hunsberger, Sally, Ana M. Ortega‐Villa, John H. Powers, et al.. (2020). Patterns of signs, symptoms, and laboratory values associated with Zika, dengue, and undefined acute illnesses in a dengue endemic region: Secondary analysis of a prospective cohort study in southern Mexico. International Journal of Infectious Diseases. 98. 241–249. 11 indexed citations

Dean, Natalie E., Ron Brookmeyer, Victor De Gruttola, et al.. (2019). Design of vaccine efficacy trials during public health emergencies. Science Translational Medicine. 11(499). 41 indexed citations

Janes, Holly, Deborah Donnell, & Martha Nason. (2019). Designing the Next Generation of HIV Prevention Efficacy Trials: Synopsis of a 2018 Symposium. 11(1). 2 indexed citations

Janes, Holly, Deborah Donnell, Peter B. Gilbert, Elizabeth R. Brown, & Martha Nason. (2019). Taking stock of the present and looking ahead: envisioning challenges in the design of future HIV prevention efficacy trials. The Lancet HIV. 6(7). e475–e482. 15 indexed citations

Gautam, Rajeev, Yoshiaki Nishimura, Amarendra Pegu, et al.. (2016). A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges. Nature. 533(7601). 105–109. 219 indexed citations

Laeyendecker, Oliver, Andrew D. Redd, Martha Nason, et al.. (2015). Antibody Maturation in Women Who Acquire HIV Infection While Using Antiretroviral Preexposure Prophylaxis. The Journal of Infectious Diseases. 212(5). 754–759. 21 indexed citations

10.

Sarwar, Uzma, Laura Novik, Mary E. Enama, et al.. (2014). Homologous Boosting with Adenoviral Serotype 5 HIV Vaccine (rAd5) Vector Can Boost Antibody Responses despite Preexisting Vector-Specific Immunity in a Randomized Phase I Clinical Trial. PLoS ONE. 9(9). e106240–e106240. 5 indexed citations

11.

Huang, Yunda, Shelly Karuna, Holly Janes, et al.. (2014). Use of placebos in Phase 1 preventive HIV vaccine clinical trials. Vaccine. 33(6). 749–752. 1 indexed citations

12.

Mahnke, Yolanda D., Kaimei Song, Mariana M. Sauer, et al.. (2012). Early immunologic and virologic predictors of clinical HIV-1 disease progression. AIDS. 27(5). 697–706. 12 indexed citations

13.

Sandler, Netanya G., Handan Wand, Annelys Roque, et al.. (2011). Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection. The Journal of Infectious Diseases. 203(6). 780–790. 856 indexed citations breakdown →

14.

Roederer, Mario, et al.. (2011). SPICE: Exploration and analysis of post‐cytometric complex multivariate datasets. Cytometry Part A. 79A(2). 167–174. 614 indexed citations breakdown →

15.

Willey, Ronald L., Martha Nason, Yoshiaki Nishimura, Dean Follmann, & Malcolm A. Martin. (2010). Neutralizing Antibody Titers Conferring Protection to Macaques from a Simian/Human Immunodeficiency Virus Challenge Using the TZM-bl Assay. AIDS Research and Human Retroviruses. 26(1). 89–98. 33 indexed citations

16.

Wu, Xueling, Anna Sambor, Martha Nason, et al.. (2008). Soluble CD4 broadens neutralization of V3-directed monoclonal antibodies and guinea pig vaccine sera against HIV-1 subtype B and C reference viruses. Virology. 380(2). 285–295. 31 indexed citations

17.

Proschan, Michael A. & Martha Nason. (2008). Conditioning in 2 × 2 Tables. Biometrics. 65(1). 316–322. 7 indexed citations

18.

Read, Sarah W., Jeanette Higgins, Julia A. Metcalf, et al.. (2006). Decreased CD127 Expression on T Cells in HIV-1-infected Adults Receiving Antiretroviral Therapy With or Without Intermittent IL-2 Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 42(5). 537–544. 21 indexed citations

19.

Madigan, David & Martha Nason. (2002). Data reduction: sampling. Oxford University Press eBooks. 205–208. 1 indexed citations

20.

Schaffner, Andrew, et al.. (1996). Benchmark lessons and the world wide web: tools for teaching statistics. International Conference of Learning Sciences. 480–485. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact